Metaxalone
NDC 0527-1435, Metaxalone, tablet, from Lannett Company, Inc..
- Product NDC
- 0527-1435
- Status
- Listed
- Labeler
- Lannett Company, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204770
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0527-1435 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- METAXALONE800 mg/1
Pharmacologic classes
Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0527-1435-01 | 00527143501 | 100 TABLET in 1 BOTTLE (0527-1435-01) |
| 0527-1435-05 | 00527143505 | 500 TABLET in 1 BOTTLE (0527-1435-05) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/8294bb3c-c8eb-474c-b567-e53cf81249e9NADAC price for package 00527143501
GET /v1/drugs/nadac/00527143501
Use it
Look up 0527-1435 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0527-1435 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0527-1435. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.